Altium Capital Management LLC Q1 2025 Filing
Filed May 9, 2025
Portfolio Value
$43.8B
Holdings
23
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (23 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ZVRAZEVRA THERAPEUTICS INC | 1,287,333 | $9.6B | 22.02% | |
| 2 | ALNYALNYLAM PHARMACEUTICALS INC | 25,000 | $6.8B | 15.42% | Put |
| 3 | EOLSEVOLUS INC | 296,193 | $3.6B | 8.14% | |
| 4 | XTNTXTANT MED HLDGS INC | 7,252,998 | $3.4B | 7.78% | |
| 5 | AVDLAVADEL PHARMACEUTICALS PLC | 419,131 | $3.3B | 7.49% | |
| 6 | XENEXENON PHARMACEUTICALS INC | 69,651 | $2.3B | 5.34% | Call |
| 7 | CTNMCONTINEUM THERAPEUTICS INC | 303,857 | $2.1B | 4.84% | |
| 8 | PRNPROFOUND MED CORP | 360,589 | $2.1B | 4.79% | |
| 9 | —LOGICMARK INC | 98,325,683 | $1.9B | 4.45% | |
| 10 | EPIEURESSA PHARMA INC | 1,050,369 | $1.7B | 3.79% | |
| 11 | SKYESKYE BIOSCIENCE INC | 904,865 | $1.4B | 3.29% | |
| 12 | ACOGALPHA COGNITION INC | 177,416 | $897.7M | 2.05% | |
| 13 | RZLTREZOLUTE INC | 303,949 | $881.5M | 2.01% | |
| 14 | NKTREURNEKTAR THERAPEUTICS | 1,051,379 | $714.9M | 1.63% | |
| 15 | AVRANTERIS TECHNOLOGIES GLOBAL | 168,589 | $613.7M | 1.40% | |
| 16 | LRMRLARIMAR THERAPEUTICS INC | 273,204 | $587.4M | 1.34% | |
| 17 | STSSSHARPS TECHNOLOGY INC | 18,737,471 | $560.3M | 1.28% | |
| 18 | PMNEURPROMIS NEUROSCIENCES INC | 574,248 | $399.4M | 0.91% | |
| 19 | NVNOENVVENO MEDICAL CORPORATION | 123,256 | $324.2M | 0.74% | |
| 20 | GBS1EURINTELLIGENT BIO SOLUTIONS IN | 149,252 | $214.9M | 0.49% | |
| 21 | KPTIKARYOPHARM THERAPEUTICS INC | 49,333 | $184.5M | 0.42% | |
| 22 | SBFMSUNSHINE BIOPHARMA INC | 50,466 | $96.4M | 0.22% | |
| 23 | SRXHBETTER CHOICE CO INC | 38,984 | $67.1M | 0.15% |